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Selected Biochemical Actions of
Ovarian Hormones
by Kenneth S. Korach*
This review is concerned with a general discussion of the actions of ovarian hormones,
including relaxin, a polypeptide hormone, and estrogens and progestogens, which are two types
of steroid hormones. Particular emphasis is placed on describing the sites of action and target
organ responses induced by the two steroid hormones. A detailed description of estrogen
activity in reproductive tract tissue is given as an example of the intracellular mechanism of
action of this steroid hormone.
Ovarian Secretion
Two types of biochemical compounds with hor-
monal activity are synthesized and secreted by
ovarian tissue. One is a polypeptide hormone,
originally described some years ago by Hisaw (1),
termed relaxin. The second is a class ofcompounds
with steroidal structure which includes androgens,
estrogens and progestogens. The ovary possesses
the enzymatic capability to synthesize all three
types ofsteroids. Such activities are localized in the
luteal and interstitial compartments for androgen
and progestin synthesis (2). Estrogenic steroids
appear to arise from thecal and granulosa cell
elements ofthe ovary (3). This discussion ofovarian
steroid action within the female will center on
estrogens and progestogens, since they are consid-
ered to be the primary steroids secreted by the
ovary. Although the actions of these steroid hor-
mones are of primary concern, a brief mention of
our present knowledge of the action of relaxin will
also be made.
Polypeptide Hormones
Relaxin has been described as a simple protein
being composed of two polypeptide chains and
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having a molecular weight of approximately 6000
daltons (4). The hormonal activity described has
beenclassically detectedduringpregnancyinplasma
and urine extracts. As mentioned earlier, the
material is of ovarian origin and recent reports
have indicated its localization in corpora lutea (5).
Its exact biological function is unclear, but in the
human the action of relaxing and dilating cervical
and vaginal tissue just prior to and during parturi-
tion is the presently accepted notion. In laboratory
animals, relaxin has been shown to cause dilation of
the cervix in mice and rats (1), a lengthening ofthe
pubic symphysis of mice and guinea pigs (6), and
inhibition of uterine contraction in rats and guinea
pigs. These effects would suggest a general action
on the smooth muscle in reproductive tract tissue.
The biochemical mechanism of relaxin action in a
target cell is unknown, but recent work indicates
the hormone binds with high affinity (Ka - 109-010
M-1) and specificity to a membrane-associated re-
ceptor from rat uteri (7). Since this binding is
enhanced by estrogens, it would appear to be of
physiological importance. At parturition, estrogen
levels are high, thereby aiding in the binding and
action of relaxin. Relaxin has also been shown to
increase cyclic nucleotide levels in uterine tissue
and may in part express its activity on smooth
muscle via a cyclic AMP mechanism (8). A specific
radioimmunoassay for relaxin has been developed
recently (9); this technique in combination with
more detailed biochemical studies may aid in eluci-







FIGURE 1. Primary sites of action of estrogens and pro
gestogens in the female.
Steroid Hormones
Ovarian steroidogenesis has been studied for
many years (10). The role ofthese steroid hormones
and their influence on gonadotropin secretion and
ovulation has been reviewed by Ross and Vande
Wiele (11). Figure 1 is a generalized view oftarget
sites in the female forthe two main types ofovarian
steroids. It should be pointed out that these ste-
roids also have effects on secondary and accessory
sex structures as well as general body metabolism.
An example is premenstrual edema which has been
associated with the midcycle and luteal phase
increases in estrogen secretion: A cause/effect rela-
tionship has been shown to involve an increased
retention ofsodium, chloride, and water correlated
to estrogen levels (12). An exact mechanistic de-
scription of this action is complicated by the pres-
ence and interrelationships between estrogens and
adrenocortical hormones. Estrogens have effects
on bone and skeletal tissue. Growth of the long
bones is retarded by estrogens acting on the
ossification process of the epiphyseal plate. Post-
menopausal osteoporosis is believed to be related to
the low estrogen levels which can no longer inhibit
the bone resorption activity of parathyroid hor-
mone (13).
Neuroendocrine
Neural responses to estrogens and progestogens
are customarily involved with the stimulation and/or
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inhibition of gonadotropin secretion occurring in
hypothalamic and pituitary tissue. Numerous stud-
ies have addressed the question ofsteroid negative
feedback at neural centers (14, 15). This topic will
be briefly reviewed here, since more detailed de-
scriptions have been published elsewhere (16).
Estrogen steroid hormones are believed to be
localized because ofthe high concentration oftarget
cell/neurons in various neural areas such as the
pre-optic anterior hypothalamus and the median
eminence-basal hypothalamus (17). Specific estro-
gen receptors have been demonstrated in these
hypothalamic areas (18). Functionally, neurons in
these areas are influenced by steroids to increase
the secretion of releasing hormones, in particular
luteinizing hormone releasing hormone (LHRH)
(19). This action then results in the stimulation of
the anterior pituitary to release gonadotropins
(e.g., LH). The exact intracellular mechanism for
these actions in the hypothalamus and pituitary is
presently unclear. Recent studies using in vitro
preparations of pituitary cells are attempting to
elucidate this mechanism on gonadotropin secretion
(20).
Progestogens have been shown to bind to specific
intracellular receptors with significant localization
in the anterior pituitary and pre-optic anterior
hypothalamus (15, 16). Karavolas and associates
have suggested that the active form ofthe proges-
togens is not progesterone but a 5ox- or 51-
dihydroprogesterone (DHP) metabolite (21). This is
similar to the actions of androgen steroids and the
determination of dihydrotestosterone (DHT) as an
active form of this class of steroids in peripheral
androgen-responsive organs (22). Although proges-
togens have not been linked to the negative feed-
back cycle ofgonadotropin secretion, their action in
these neurosites has been associated with sexual
behavior and the facilitation of ovulation (15).
Mammary Gland and Liver
The mammary gland has received much attention
as a steroid target tissue with the recent increased
incidence and interest in breast cancer. From our
present knowledge, the mammary gland exem-
plifies the complexity of multihormonal action in-
volved in expression of a physiological function.
Ovarian steroid hormones are important compounds
in certain aspects of this organ's responses. In
noncancerous tissue, estrogen has a specific pri-
mary effect in combination with other hormones of
stimulating epithelial cells and ductal growth of
mammary tissue (23). Progesterone, on the other
hand, in the presence of prolactin stimulates the
morphogenesis of mammary gland alveoli (24).
Environmental Health PerspectivesThere is no apparent action of estrogen in the
lobular alveolar structures. This is a clear example
ofthe two ovarian steroids acting independently on
specific tissue cell types within a target organ.
Normal growth ofthe mammary gland requires the
presence of both estrogens and progestogens as
well as additional steroid and polypeptide hormones
(25). The phenomenon of lactation involves the
action ofthe steroid hormones in properly develop-
ing and preparing the mammary gland for the
action ofprolactin. Pituitary prolactin is believed to
be the hormonal agent responsible for lactation
(26).
In recent years, the liver has been studied with
regard to endocrine controls. There has been little
evidence suggesting an action of progesterone on
liver function. The majority ofthe data and studies
have involved estrogen action on liver tissue.
Estradiol has been shown to increase specific pro-
tein syntheses in this organ independent of a
stimulation of DNA synthesis. A variety of liver
enzymes such as histidase (27) and serum cholines-
terase (28) have been shown to be preferentially
synthesized under estrogen administration. The
stimulatory action of estrogen on liver protein
synthesis is best illustrated by its effect ofincreas-
ing plasma ,B-globulins. This class of proteins con-
tains the steroid hormone binding proteins such as
corticosteroid binding globulin (CBG) and testos-
terone-estradiol binding globulin (TeBG) (29). This
action in the liver is particularly important through-
out pregnancy, during which estradiol functions to
increase plasma binding protein concentrations to a
sufficient level to maintain a proper free steroid
hormone concentration in the blood at a time ofhigh
steroid hormone secretion. Estrogennotonlystimu-
lates protein synthesis, but can also have an action
ofinhibitingthe synthesis ofaparticular protein. In
this case, estrogen treatment has been shown to
decrease the level of aL2u-globulin synthesized in
the liver. Detailed studies of this effect have
indicated the action involves an actual decrease in
the level of mRNA for the protein (30).
In recent years an association between oral
contraceptives and liver disease has been indicated.
Evidence suggests that the estrogen component of
oral contraceptives is possibly related to these,
abnormalities in hepatic excretory function (31). It
is not certain how the estrogens may work to
influence liver function, but current studies have
indicated an estrogen receptor mechanism present
in liver cells similar to those described in other
target tissues, such as the uterus or pituitary (32).
A more detailed discussion of various controls and
programming events in the liver can be found in an
additional section of this volume (33).
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Ovary
It was mentioned earlier that estrogens have a
positive effect on gonadotropin secretion from the
pituitary gland (14). There are a number of studies
that suggest a stimulating action of the ovarian
hormones on various tissue elements of the ovary
(34). It has been shown in hypophysectomized
animals that estrogens in high doses are capable of
stimulating the development of ovarian follicles
from small to medium size (35). In particular, the
granulosa cells which are found lining the follicle
are stimulated by estrogen. Another action of
estrogen in the ovary is the enhancement of the
effects ofgonadotropins (36). The exact mechanism
of this enhancement is not clear, but it does not
involve an estrogen stimulation or induction of
gonadotropin receptors. Rather, the effect is pro-
duced by estrogen influences on FSH to stimulate
its own receptors as well as those for LH. On the
otherhand, a direct role for the action ofprogester-
one on the ovary has not been clearly demonstrated
to date, but the effect may be indirect via an action
in the anterior pituitary on gonadotropin secretion.
Reproductive Tract
One ofthe main sites ofaction for ovarian steroid
hormones is the reproductive tract of the female.
The vagina, cervix, and uterus respond to ovarian
steroids in their own individual manner to produce
a collective physiological response which is essen-
tial for a successful reproductive cycle. We will
briefly describe general actions ofthe two classes of
ovarian steroids on these individual organs before
discussing the action of estrogens in the uterus in
more detail.
In the vagina, estrogen steroids act to increase
cell proliferation and stratification ofthe epithelium
which subsequently undergoes cornification. The
cornification process results in the appearance of
cornified cells in the vaginal smear which can be
used diagnostically as an indication of estrogen
stimulation. A second primary estrogenic response
in vaginal tissue involves the lowering ofthe pH of
vaginal secretions. This acidification occurs by way
of an estrogen stimulation ofglycogen formation in
vaginal epithelial cells. Glycolysis then ensues and
the glycogen is converted to lactic acid. The in-
crease in lactic acid in these cells and subsequently
in the secretions produces the lower pH. It is
believed that these basic actions of estrogen on
vaginal tissue provide a defense against vaginal
infections. Progesterone action in the vagina is
quite different than that ofestrogen. Progesterone
exposure stimulates mucus secretion. A microscopic
41observation of the vaginal secretion will now show
few cornified cells as with estrogen, but rather, an
increased number of leukocytes present in the
secretion.
In contrast, the actions of the two types of
steroids are quite different in cervical tissue. Es-
trogen stimulates mucus secretion which is of low
viscosity and exhibits an alkaline pH. Presumably,
this aids in sperm transport and survival resulting
in increased reproductive success. Progesterone
produces a reduction in the amount of mucus
secreted, in addition to a thickening of the secre-
tion. This, in fact, was thought of as a possible
contraceptive mechanism whereby progesterone
agents could be given to increase the viscosity of
the cervical mucus resulting in a retardation of
sperm motility and penetrability in the female
reproductive tract.
One of the most dramatic effects of steroid
hormones on mammalian reproductive tract tissue
occurs in the endometrial lining of the uterus. In
the case of estrogen, laboratory animal studies
have indicated that stimulation appears to occur in
twophases: anearly phase from 0to 6 hrand asecond
growth phase from 6 to 24 hr (37). This later mito-
genic response involves both hypertrophy and hy-
perplasia responses within the tissue (38). The size
and weight ofthe uterus increases some 3- to 4-fold
over the nonstimulated state. There is an increase
in cell number with the luminal epithelial cells
changing from a cuboidal to a columnar type ofcell.
General cellular metabolism is increased with a
variety of enzymes such as glucose 6-phosphate
dehydrogenase(39)beingspecificallyinduced. Water
imbibition occurs to a marked extent, and there is
pronounced hyperemia in the tissue. Finally, the
tissue shows significant increases in RNA and DNA
synthesis with mitosis occurring by 16-24 hr after
estrogen stimulation. In general, progesterone acts
in the rodent and primate uterus to change the
estrogen induced proliferative endometrium into a
secretory endometrium (11); this also results in
inhibition of any further luminal epithelial cell
proliferation (40). Such a physiological change in
the tissue aids the endometrial lining in nidation of
the fertilized ovum. If pregnancy does not ensue
then menses results. The exact intracellular mech-
anism for this progesterone action in the uterine
endometrium is unclear, but estrogen stimulation is
aprerequisite to induce progesterone receptor. The
progesterone acts to limit the estrogen receptor
replenishment (41), thereby minimizing the estro-
gen effect on the tissue. In certain species, such as
the dog, cat, and rabbit, uterine growth is stimu-
lated by progesterone rather than estrogen (42).
The experimental evidence involved with estrogen
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GENERALIZED MODEL OF ESTROGEN ACTION IN TARGET CELLS
FIGURE 2. A generalized model ofestrogen hormone action in
uterine target cells.
stimulation of uterine growth has come primarily
from studies using the rat uterus. There have been
several reviews which have concentrated on this
species (37, 43).
Mechanism of Intracellular Action
of Estrogen
A generalized model forthe intracellular action of
estrogen hormone is diagramatically illustrated in
Figure 2. The hormone enters the cell through
passive diffusion and interacts with a cytoplasmic
receptor exhibiting a high binding affinity for the
hormone (44). The hormone-receptor complex then
undergoes a change in physical state to an "activat-
ed" form (45). In this "activated" state, the
hormone-receptor complex can then translocate to
the nucleus of the target cell. Once inside the
nucleus, the complex is believed to interact with an
acceptor site(s) at specific areas of the genome. A
precise description ofthe nuclearinteractions ofthe
hormone complex as well as the molecular biology
of gene expression in uterine tissue is presently
incomplete. The reader is directed to studies using
the chick oviduct as a model system for these
research areas (46, 47).
Following the interaction in the genome, specific
messenger RNA is transcribed with subsequent
translation to specific proteins. As mentioned earli-
er, glucose 6-phosphate dehydrogenase is an exam-
ple of such an action (39) in addition to a protein
termed IP or "induced protein" (48). After such
initial RNA and protein synthetic events occur, the
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HORMONE BINDS TO CYTOPLASMIC RECEPTOR
TIME (HRS) BIOCHEMICAL EVENTS IN
THE MOUSE UTERUS
FIGURE 3. A temporal pattern of biochemical events which
occur in the mouse uterus after estrogen stimulation.
lined in Figure 3. Hormone-receptor complex is
continuously lost from the nucleus after the initial
interaction at approximately 1 hr. The receptor
level in the cytoplasm is then replenished through
recycling and synthesis (41). Induction of proges-
terone receptor by estrogen is also occurring in the
cell at this time and has been clearly documented
(49). These events, in addition to an increase in
nuclear proteins and DNA synthesis finally results
in mitosis and cell division.
As mentioned earlier, the rodent uterus, in
particular, the rat uterus, has been studied exten-
sively as a model system for certain aspects of
estrogen action. A question which commonly arises
in endocrine and/or toxicological studies involves
the best choice of species for conducting certain
experiments. Since the mouse has been utilized in
various toxicological (50) and carcinogenic (51)
studies and since the responses in the rat uterus
have been previously summarized (43), it seemed
worthwhile, in this chapter, to summarize the
normal biochemical responses ofthe mouse uterus.
Hopefully, this may be of some aid and reference to
other investigators using this species. In Figure 3
is a temporal listing of various biochemical events
which have been described in the mouse uterus
after estrogen stimulation. These data come from a
number ofstudies both in this laboratory (52-55) as
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FIGURE 4. Temporal pattern of DNA synthesis measured in
the castrate mouse uterus after a single IP injection of 20
,g/kg estradiol. DNA synthesis was quantified by the
procedure outlined by Harris and Gorski (57).
well as those of others (38, 40, 42). Certain re-
sponses, such as the early events involving the
receptor, water imbibition, wet weight increase,
and increased vascularity and hyperemia appear to
be similar in most species. However, there are also
some species differences in the cellular response to
estrogens. For example, in the CD-1 mouse, there
is a second nuclear increase in hormone-receptor
complex (52), which appears to be related to the
late growth response (53), but clear evidence of
such an increase in the rat is not presently avail-
able. One of the most significant endpoints of
estrogen action in the uterus involves stimulation of
DNA synthesis. Figure 4 shows the temporal
pattern of DNA. synthesis in the castrate mouse
uterus following a single injection 20 ,ug/kg estradi-
ol. A significant net increase in synthesis occurs
around 6-8 hr, while in the rat this increase occurs
around 12 hr (43). There are two peaks of DNA
synthetic activity occurring; the first is at 16 hr and
quantitatively is the largest; a second and smaller
response occurs at 24 hr. These two peaks of DNA
synthesis are also accompanied by two waves of
mitosis (56) which occur at approximately the same
time. Studies using the rat uterus have not indicat-
ed similar findings.
The biphasic nature ofthe responses shown here
for the mouse uterus may be related in part to the
differential responses seen in the stromal and
epithelial cell compartments (38, 40). Those studies
illustrated in adult castrate animals that estrogen
stimulates cell division primarily in epithelial cells
even though steroid hormone was localized in the
nuclei ofboth cell types. When this localization was
further investigated as a temporal event, prelimi-
nary studies using autoradiographic techniques
demonstrated a differential nuclear uptake of hor-
mone in the mouse uterine tissue (58). The glandu-
lar epithelium and stromal cells showed nuclear
localization early after hormone administration (1
43hr) while luminal epithelial cells did not show
significant nuclear accumulation of hormone until
7-8 hr. One explanation for such findings maybe the
requirement for hormone interaction in one cell
compartment (stroma/glandular epithelium) which
then influences hormone uptake and/or response in
another cell compartment (luminal epithelium).
Whether this mechanism involves the synthesis of
some factor awaits further experimentation; al-
though, the existence of tissue factors have been
suggested from studies investigating the differen-
tiation and development of reproductive tract tis-
sue (59). In those studies using tissue recombinants
it was shown that the stromal cell compartment had
influence on its overlying epithelium. Therefore, it
seems reasonable to expect that future studies both
toxicological and/or endocrine in nature, should
consider that target organs may exhibit a different
responsiveness and/or effect in various tissue com-
partments.
Summary
This review has intended to describe the basic
sites of action and the diversity of responses
induced by ovarian hormones. In addition, the
detail and complexity of target organ respones, as
well as the differences in animal species responses
to the hormone have been illustrated. Hopefully, an
appreciation of these points may be useful in
understanding various toxicological problems as
well as the actions of environmental compounds
which may possess similar hormonal activity.
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